Today’s guest post comes from Sarah Alwardt, Vice President of Operations at Ontada.
Sarah describes how historical patient information can be used in current and future clinical trials, often eliminating the need for new trial participants. She also introduces us to Ontada, a new McKesson business that uses technology, real-world data, and research capabilities as a way to accelerate innovation and improve cancer therapies.
To learn more, visit the Ontada website.
Read more »
Source: Post feed
